Investor Presentaiton

Sartorius Group Limited dependence on individual accounts Long-term business relationships with leading global (bio-) pharma companies Limited dependence on individual accounts Sales to Top 50 customers in 2023, € in millions gsk GlaxoSmithKline SAMSUNG BIOLOGICS Boehringer Ingelheim 800 ~57 600 ~52 ~47 Lonza Roche Pfizer ~39 400 ~26 SANOFI 200 AMGEN 0 REGENERON More than half of 2023 BPS sales were generated with the Top 50 customers MSD Top 10 11 to 20 21 to 30 31 to 40 41 to 50 Sales Cumulative Share ☐ 27 No individual customer accounts for more than 5% of BPS sales revenue SARTORIUS

View entire presentation